Stocks
BioMarin Pharmaceutical (BMRN) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 342.2 | -0.75 | 0.07 | 18.4 | 18.3 | 20.2 | ||
| Changes by years, y/y, % | +80% | -100% | -110% | +25 696% | -1% | -37.4% | |||
BioMarin Pharmaceutical. EV/EBITDA
BioMarin Pharmaceutical. EV/EBITDA, changes, %
BioMarin Pharmaceutical (BMRN) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EV/EBITDA | ? | 10.4 | 12.3 | 18.3 | 20.9 | 37.3 | 20.2 | |
| Changes by years, y/y, % | -3 608% | -52% | -1% | +27% | +259% | |||
| Changes by quarters, q/q, % | -37% | +19% | +48% | +14% | +78% | |||
